1. Targeting BCMA in Multiple Myeloma

   • Carlyn Rose Tan
   • Urvi A. Shah

   Multiple Myeloma (P Kapoor, Section Editor) 25 August 2021 Pages: 367 - 383

   

2. Acute Lymphoblastic Leukemia and Acute Lymphoblastic Lymphoma: Same Disease Spectrum but Two Distinct Diagnoses

   • Kathryn A. F. Kline
   • Michael E. Kallen
   • Jennie Y. Law

   Acute Lymphocytic Leukemias (M Keng and F El Chaer, Section Editors) 21 August 2021 Pages: 384 - 393

   

3. Application of Next-Generation Sequencing-Based Mutational Profiling in Acute Lymphoblastic Leukemia

   • Ahmed Aleem
   • Ali R. Haque
   • Elizabeth A. Griffiths

   Acute Lymphocytic Leukemias (M Keng and F El Chaer, Section Editors) 06 October 2021 Pages: 394 - 404

   

4. Management and Outcomes of Blast Transformed Chronic Myelomonocytic Leukemia

   • Danielle Hammond
   • Guillermo Montalban-Bravo

   Myelodysplastic Syndromes and MPN/MDS Overlap (M Patnaik, Section Editor) 09 September 2021 Pages: 405 - 417

   

5. Elevating Twitter-Based Journal Club Discussions by Leveraging a Voice-Based Platform: #HemepathJC Meets Clubhouse

   • Aadil Ahmed
   • Kamran M. Mirza
   • Sanam Loghavi

   Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor) 29 September 2021 Pages: 418 - 421

   

6. BTK Inhibitors in Chronic Lymphocytic Leukemia

   • Sameh Gaballa
   • Javier Pinilla-Ibarz

   Chronic Lymphocytic Leukemias (N Jain, Section Editor) 02 October 2021 Pages: 422 - 432

   

7. Treatment-Free Remission: the New Goal in CML Therapy

   • Ehab Atallah
   • Kendra Sweet

   Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors) 07 October 2021 Pages: 433 - 439

8. Challenges in Chronic Myeloid Leukemia Management in South America

   • Katia B. Pagnano
   • Ana Ines Varela
   • Virginia Abello Polo

   Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors) 15 October 2021 Pages: 440 - 447

9. The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML)

   • Heather R. Wolfe
   • Lindsay A. M. Rein

   Chronic Myeloid Leukemias (MJ Mauro and G Saglio, Section Editors) 18 October 2021 Pages: 448 - 454

10. Philadelphia-Negative Myeloproliferative Neoplasms Around the COVID-19 Pandemic

    • Tiziano Barbui
    • Valerio De Stefano

    Myeloproliferative Neoplasms (BL Stein, Section Editor) 29 September 2021 Pages: 455 - 463

    

11. Avapritinib in the Treatment of Systemic Mastocytosis: an Update

    • Samantha Below
    • Laura C. Michaelis

    Myeloproliferative Neoplasms (BL Stein, Section Editor) 27 September 2021 Pages: 464 - 472

    

12. Management Issues and Controversies in Low-Risk Patients with Essential Thrombocythemia and Polycythemia Vera

    • Joan How
    • Gabriela Hobbs

    Myeloproliferative Neoplasms (BL Stein, Section Editor) 03 September 2021 Pages: 473 - 482

    

13. Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials

    • Brady L. Stein

    Myeloproliferative Neoplasms (BL Stein, Section Editor) 09 September 2021 Pages: 483 - 489